Optimizing safety surveillance for COVID-19 vaccines #MMPMID32555401
Chandler RE
Nat Rev Immunol 2020[Aug]; 20 (8): 451-452 PMID32555401show ga
Evolution of the current infrastructure for surveillance of vaccine safety will be essential to meet our commitments to the public in the deployment of a vaccine (or vaccines) to COVID-19. The incorporation of concepts and tools within the fields of data science and systems immunology can be used to propel vaccine safety monitoring into the twenty-first century.